Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Bristol-Myers Squibb Co

+ Add to Watchlist

BMY:US

61.9900 USD 0.4700 0.75%

As of 20:04:07 ET on 01/27/2015.

Snapshot for Bristol-Myers Squibb Co (BMY)

Open: 61.8600 Day's Range: 61.0000 - 62.9900 Volume: 7,767,830
Previous Close: 62.4600 52wk Range: 46.3000 - 64.4400 1-Yr Rtn: +24.79%

Stock Chart for BMY

No chart data available.
  • BMY:US 61.9900
  • 1D
  • 1M
  • 1Y
62.4600
Interactive BMY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BMY

Current P/E Ratio (ttm) 47.5506
Estimated P/E(12/2015) 35.8946
Relative P/E vs. SPX 2.6632
Earnings Per Share (USD) (ttm) 1.3037
Est. EPS (USD) (12/2015) 1.7270
Est. PEG Ratio 2.2271
Market Cap (M USD) 102,827.55
Shares Outstanding (M) 1,658.78
30 Day Average Volume 6,614,607
Price/Book (mrq) 6.7586
Price/Sale (ttm) 6.4682
Dividend Indicated Gross Yield 2.39%
Cash Dividend (USD) 0.3700
Dividend Ex-Date 12/30/2014
5 Year Dividend Growth 3.01%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BMY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BMY

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Lamberto AndreottiChief Executive OfficerGiovanni CaforioChief Operating Officer
Louis S SchmuklerPres:Global ManufacturingMurdo GordonPresident:US
More Company Profile & Key Executives for BMY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil